These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7009759)

  • 1. Differential graft resistance of C3H mice pretreated with antitumor drugs against BALB/c bone marrow or lymphoma cells.
    Campanile F; Bonmassar E
    J Immunopharmacol; 1980; 2(4):527-42. PubMed ID: 7009759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplantation resistance of drug-treated allogeneic mice against murine lymphomas--II. Studies with various tumor-host combinations.
    Bonmassar A; Rivosecchi-Merletti P; Barzi A; Goldin A; Bonmassar E
    Int J Immunopharmacol; 1981; 3(4):391-9. PubMed ID: 7333720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural resistance of mice pretreated with 5-(3,3'-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) + cyclophosphamide (Cy) against virus-induced lymphoma cells.
    Campanile F; Iorio AM; Bonmassar E
    Int J Immunopharmacol; 1984; 6(4):251-8. PubMed ID: 6480192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplantation resistance of drug-treated hybrid or allogeneic mice against murine lymphomas. I. Immunopharmacology studies.
    Bonmassar A; Riccardi C; Rivosecchi-Merletti P; Goldin A; Bonmassar E
    Int J Cancer; 1980 Dec; 26(6):819-29. PubMed ID: 6971268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunodepressive and hematotoxic activity of imidazole-4-carboxamide,5-(3,3-dimethyl-1-triazeno) in mice.
    Vecchi A; Fioretti MC; Mantovani A; Barzi A; Spreafico F
    Transplantation; 1976 Dec; 22(6):619-24. PubMed ID: 795112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of purified CD8+ T cells in graft-versus-leukemia activity and engraftment after allogeneic bone marrow transplantation.
    Palathumpat V; Dejbakhsh-Jones S; Strober S
    Transplantation; 1995 Aug; 60(4):355-61. PubMed ID: 7652765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graft-versus-leukemia activity after bone marrow transplantation does not require graft-versus-host disease.
    Glass B; Uharek L; Gassmann W; Focks B; Bolouri H; Loeffler H; Mueller-Ruchholtz W
    Ann Hematol; 1992 Jun; 64(6):255-9. PubMed ID: 1637877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of lymphokine-activated killer cells to prevent bone marrow graft rejection and lethal graft-vs-host disease.
    Azuma E; Yamamoto H; Kaplan J
    J Immunol; 1989 Sep; 143(5):1524-9. PubMed ID: 2668409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-mediated increase of tumor immunogenicity in vivo for a new approach to experimental cancer immunotherapy.
    Giampietri A; Bonmassar A; Puccetti P; Circolo A; Goldin A; Bonmassar E
    Cancer Res; 1981 Feb; 41(2):681-7. PubMed ID: 7448813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow transplantation from Fv-4-resistant donors rescues Friend leukemia virus-infected mice from leukemia: a model of bone marrow transplantation therapy against retroviral infection.
    Kitagawa M; Kamisaku H; Aizawa S; Sado T
    Leukemia; 1994 Dec; 8(12):2200-6. PubMed ID: 7808008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nature of tolerance in adult recipient mice made tolerant of alloantigens with supralethal irradiation followed by syngeneic bone marrow cell transplantation plus injection of F1 spleen cells.
    Tomita Y; Himeno K; Mayumi H; Tokuda N; Nomoto K
    Transplantation; 1989 Jun; 47(6):1021-9. PubMed ID: 2660340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of BCL1 leukemia by transplantation of low density fractions of allogeneic bone marrow and spleen cells.
    Palathumpat V; Holm B; Dejbakhsh-Jones S; Strober S
    J Immunol; 1992 May; 148(10):3319-26. PubMed ID: 1578152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific inhibition of hybrid resistance in F1 hybrid mice pretreated with parent-strain spleen cells. II. Evidence for an Hh-1 antigen-specific tolerization.
    Kosmatopoulos K; Scott-Algara D; Halle-Pannenko O
    J Immunol; 1988 Nov; 141(10):3285-92. PubMed ID: 2460528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The induction of skin xenograft tolerance in rat-to-mouse combination could be affected by DFR mediating cells and antibodies against rat bone marrow cells as well as NK cells in the cyclophosphamide-induced tolerance system.
    Nishimura Y; Eto M; Maeda T; Hiromatsu K; Nomoto K; Kong YY; Nomoto K
    Immunobiology; 1995 Aug; 193(5):420-38. PubMed ID: 8522358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-reactions between tumor cells and allogeneic normal tissues. Inhibition of a syngeneic lymphoma outgrowth in H-2 and non-H-2 alloimmune BALB/c mice.
    Parmiani G; Sensi ML; Carbone G; Colombo M; Pierotti M; Ballinari D; Hilgers J; Hilkens J
    Int J Cancer; 1982 Mar; 29(3):323-32. PubMed ID: 7068280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intrasplenic injection of allogeneic bone marrow cells on the survival of lethally X-irradiated mice.
    Imamura M; Miyazaki T; Okabe M; Sakurada K; Musashi M; Kawamura K; Hatakeyama M
    Transplantation; 1983 Jan; 35(1):19-24. PubMed ID: 6337432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo administration of interleukin-6 in murine allogeneic bone marrow chimeras: early and delayed enhancement of hematopoiesis accompanied with split tolerance but not with graft-versus-host disease.
    Imamura M; Hashino S; Kobayashi H; Tanaka J; Imai K; Han M; Fujii Y; Kobayashi M; Higa T; Kasai M
    Immunobiology; 1994 Jun; 190(4-5):346-67. PubMed ID: 7982720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Creation of chimeric hearts: a tool for testing the "passenger leukocyte" hypothesis.
    Eiref SD; Zhang W; Popma SH; Shah LJ; Moore JS; Rosengard BR
    Ann Thorac Surg; 1997 Sep; 64(3):628-33. PubMed ID: 9307449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The necessity of both allogeneic antigens and stem cells for cyclophosphamide-induced skin allograft tolerance in mice.
    Mayumi H; Good RA
    Immunobiology; 1989 Feb; 178(4-5):287-304. PubMed ID: 2565882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second-set rejection of mouse liver allografts is dependent on radiation-sensitive nonparenchymal cells of graft bone marrow origin.
    Fu F; Thai NL; Li Y; Lu L; Thomson AW; Fung JJ; Qian S
    Transplantation; 1996 Apr; 61(8):1228-33. PubMed ID: 8610423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.